4- methyl- 2,4- bis(4- hydroxyphenyl)pent- 1- ene
bisphenol A metabolite; structure in first source
Networked: 3
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Hirao-Suzuki, Masayo:
3 articles
(01/2021 - 01/2019)
|
| 2. | Takeda, Shuso:
2 articles
(01/2021 - 01/2019)
|
| 3. | Takiguchi, Masufumi:
2 articles
(01/2021 - 01/2019)
|
| 4. | Yoshihara, Shin'ichi:
2 articles
(01/2021 - 01/2019)
|
| 5. | Nagase, Keita:
1 article
(01/2021)
|
| 6. | Shigemori, Egao:
1 article
(01/2021)
|
| 7. | Suemori, Tatsuya:
1 article
(01/2021)
|
| 8. | Sugihara, Narumi:
1 article
(01/2021)
|
| 9. | Tanaka, Michitaka:
1 article
(01/2021)
|
| 10. | Tsutsumi, Kana:
1 article
(01/2021)
|
Related Diseases
| 1. | Breast Neoplasms (Breast Cancer)
01/01/2021
- " We have recently reported that 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP), an active metabolite of bisphenol A, in ERα/β-positive human breast cancer significantly down-regulates ERα expression, yet stimulates cell proliferation through the activation of ERβ-mediated transcription. " 01/01/2019
- " Repeated Exposure to 4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP), an Active Metabolite of Bisphenol A, Aggressively Stimulates Breast Cancer Cell Growth in an Estrogen Receptor β (ERβ)-Dependent Manner." 01/01/2021
- " 4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP) Targets Estrogen Receptor β, to Evoke the Resistance of Human Breast Cancer MCF-7 Cells to G-1, an Agonist for G Protein-Coupled Estrogen Receptor 1."
|
|
Related Drugs and Biologics